Advocates are lobbying the FDA to recognize the difference between obesity and short-term weight loss drugs, as many semaglutide products are increasingly used for weight loss.
Representatives of the STOP Obesity Alliance, The Obesity Society and the Obesity Action Coalition, met with FDA Commissioner Robert Califf...